EMEA-002033-PIP01-16-M01

Key facts

Active substance
Vosoritide (BMN 111)
Therapeutic area
Other
Decision number
P/0060/2020
PIP number
EMEA-002033-PIP01-16-M01
Pharmaceutical form(s)
Powder for solution for injection
Condition(s) / indication(s)
Treatment of achondroplasia
Route(s) of administration
Subcutaneous use
Contact for public enquiries
BioMarin International Limited
Tel. +44 2074200800
E-mail: biomarin-europe@bmrn.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating